Mednax MD reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Mednax beat their estimated earnings by 9.52%, reporting an EPS of $0.46 versus an estimate of $0.42, which did not surprise analysts.
Revenue was up $32,314,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09, which was followed by a 9.26% increase in the share price the next day.
Here's a look at Mednax's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 0.32 | 0.13 | 0.36 | 0.40 |
EPS Actual | 0.41 | 0.24 | 0.25 | 0.37 |
Revenue Estimate | 448.94M | 424.13M | 459.54M | 535.39M |
Revenue Actual | 472.96M | 446.75M | 416.63M | 460.63M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.